SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-142973
Filing Date
2019-05-09
Accepted
2019-05-09 16:10:09
Documents
63
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d710910d10q.htm 10-Q 800128
2 EX-31.1 d710910dex311.htm EX-31.1 6391
3 EX-31.2 d710910dex312.htm EX-31.2 6413
4 EX-32.1 d710910dex321.htm EX-32.1 3789
5 EX-32.2 d710910dex322.htm EX-32.2 3848
  Complete submission text file 0001193125-19-142973.txt   4174361

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kpti-20190331.xml EX-101.INS 668483
7 XBRL TAXONOMY EXTENSION SCHEMA kpti-20190331.xsd EX-101.SCH 44965
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kpti-20190331_cal.xml EX-101.CAL 66163
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kpti-20190331_def.xml EX-101.DEF 222550
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kpti-20190331_lab.xml EX-101.LAB 408312
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kpti-20190331_pre.xml EX-101.PRE 327234
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36167 | Film No.: 19810612
SIC: 2834 Pharmaceutical Preparations